QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization
Not Applicable
Completed
- Conditions
- Heart Failure
- Interventions
- Device: QuickOpt
- Registration Number
- NCT00918294
- Lead Sponsor
- Abbott Medical Devices
- Brief Summary
QuickOptTM optimization method provides a quicker, simpler and reliable alternative to standard echocardiography methods for optimization of sensed AV, paced AV and V-V delays in patients with CRT-P devices
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Patient meets current CRT-P indications and be implanted with an SJM CRT-P device with V-V timing and a compatible lead system
- Patient is able to provide written informed consent for study participation
Exclusion Criteria
- Patient has limited intrinsic atrial activity (≤ 40 bpm)
- Patient has persistent or permanent AF
- Patient has a 2o or 3o heart block
- Patient is unable to provide analyzable echocardiogram images
- Patient's life expectancy is <12 months
- Patient is <18 years old
- Patient is pregnant
- Patient is on IV inotropic agents
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description QuickOpt QuickOpt QuickOpt is an optimization algorithm to program the AV, PV and VV delays
- Primary Outcome Measures
Name Time Method To compare the aortic velocity time integral value derived by the QuickOptTM optimization method with that derived by the standard echocardiography optimization methods 1 day
- Secondary Outcome Measures
Name Time Method Effects of any spontaneous cardiac events during the QuickOpt optimization process and these events are not limited to premature ventricular complex (PVC), pacemaker-mediated tachycardia (PMT), atrial fibrillation (AF) and far-field R-wave oversensing 1 day Time required for each optimization method considered in this study 1 day
Trial Locations
- Locations (1)
Fu Wai Hospital
🇨🇳Beijing, China